125 related articles for article (PubMed ID: 9451705)
1. Prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma and multiple myeloma. A report from Japan.
Yoshikawa M; Imazu H; Ueda S; Tamagawa T; Yoneda S; Yamane Y; Takaya A; Fukui H; Nakano H
J Clin Gastroenterol; 1997 Dec; 25(4):713-4. PubMed ID: 9451705
[No Abstract] [Full Text] [Related]
2. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies.
Silvestri F; Barillari G; Fanin R; Zaja F; Infanti L; Patriarca F; Baccarani M; Pipan C; Falasca E; Botta GA
Blood; 1996 Aug; 88(3):1125-6. PubMed ID: 8704227
[No Abstract] [Full Text] [Related]
3. Number of siblings and risk of hodgkin's and other lymphoid neoplasms.
Chatenoud L; Gallus S; Altieri A; Negri E; Talamini R; Franceschi S; La Vecchia C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):552. PubMed ID: 15734990
[No Abstract] [Full Text] [Related]
4. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
Park SC; Jeong SH; Kim J; Han CJ; Kim YC; Choi KS; Cho JH; Lee M; Jung HH; Ki SS; Chang YH; Lee SS; Park YH; Lee KH
J Med Virol; 2008 Jun; 80(6):960-6. PubMed ID: 18428141
[TBL] [Abstract][Full Text] [Related]
5. Geographic aspects of malignant lymphoma and multiple myeloma. Select comparisons involving Japan, England and the United States.
Anderson RE; Ishida K; Li Y; Ishimaru T; Nishiyama H
Am J Pathol; 1970 Oct; 61(1):85-98. PubMed ID: 4922952
[No Abstract] [Full Text] [Related]
6. The pattern of haematological and lymphoreticular malignancy in Zimbabwe.
Levy LM
Trop Geogr Med; 1988 Apr; 40(2):109-14. PubMed ID: 3406999
[TBL] [Abstract][Full Text] [Related]
7. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphomas and paraproteinaemias.
Ramot B; Rechavi G
Baillieres Clin Haematol; 1992 Jan; 5(1):81-99. PubMed ID: 1317730
[No Abstract] [Full Text] [Related]
9. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
10. Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: results of a French case-control study.
Monnereau A; Orsi L; Troussard X; Berthou C; Fenaux P; Soubeyran P; Marit G; Huguet F; Milpied N; Leporrier M; Hemon D; Clavel J
Cancer Causes Control; 2008 Dec; 19(10):1147-60. PubMed ID: 18781390
[TBL] [Abstract][Full Text] [Related]
11. Malignant lymphoma.
Anderson RE
Hum Pathol; 1971 Dec; 2(4):515-9. PubMed ID: 4939264
[No Abstract] [Full Text] [Related]
12. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases.
Yenice N; Güllük F; Arican N; Türkmen S
Turk J Gastroenterol; 2003 Sep; 14(3):173-6. PubMed ID: 14655060
[TBL] [Abstract][Full Text] [Related]
13. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes.
Masala G; Di Lollo S; Picoco C; Crosignani P; Demicheli V; Fontana A; Funtó I; Miligi L; Nanni O; Papucci A; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganó C; Vindigni C; Seniori Costantini A; Vineis P
Int J Cancer; 1996 Oct; 68(2):156-9. PubMed ID: 8900420
[TBL] [Abstract][Full Text] [Related]
14. Lymphoma, myeloma and occupation: results of a case-control study.
Fritschi L; Siemiatycki J
Int J Cancer; 1996 Aug; 67(4):498-503. PubMed ID: 8759607
[TBL] [Abstract][Full Text] [Related]
15. Lympho-hemopoietic malignancies in India.
Bhutani M; Vora A; Kumar L; Kochupillai V
Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and imaging of hepatic involvement in malignant lymphoproliferative disease.
Bach AG; Behrmann C; Holzhausen HJ; Spielmann RP; Surov A
Clin Imaging; 2012; 36(5):539-46. PubMed ID: 22920359
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
18. Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin's lymphoma patients.
Iannitto E; De Cantis S; Cirrincione S; Ammatuna E; Di Trapani R; Quintini G; Carroccio A; Mariani G
J Gastroenterol Hepatol; 2002 Sep; 17(9):1039-40. PubMed ID: 12167130
[No Abstract] [Full Text] [Related]
19. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China.
Wang C; Xia B; Ning Q; Zhao H; Yang H; Zhao Z; Wang X; Wang Y; Yu Y; Zhang Y
Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease following non-Hodgkin's lymphoma.
Travis LB; Gonzalez CL; Hankey BF; Jaffe ES
Cancer; 1992 May; 69(9):2337-42. PubMed ID: 1562981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
